DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
up	IGKV3D-20; IGKV1-12; IGKV2-29; HP; JCHAIN; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHA2; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; IGLC2; IGLC3; FOLR2; IGHV1-2; FCGR2B; HBA1; IGLV3-21; CLEC9A; FCGR1B; STAB1;	GO:0006898~receptor-mediated endocytosis	57	160	35.625	0	0	0	0	0	0	0
up	IGHV3-11; IGHV4-39; IGHV3-74; IGHV1-69; IGLL5; IGHG2; IGHV3-30; IGHV1-2; IGHV4-4; IGHV3-43; IGHV4-28; TRDC; IGHV1-46; IGHV3-64; IGHV3-66; IGHV3-72; TRBC2; IGHA2; IGHV1-3; IGHV1-18; IGHV3-15; IGHV3-49; IGHV1-69-2; IGHV3-20; IGHV3-21; IGLC3; IGHV3-23; IGHV3-13; IGHV2-70; IGHV3-53; IGHG3; IGHV3-7; IGHV1-58; IGHV4-61; IGHV2-5; IGHD; IGHV2-26; TRBC1; IGHV5-51; IGHV3-73; IGLC2; IGKC; IGHV6-1; IGHV4-31; IGHV3-48; IGHV1-24; IGHV4-59; IGHV4-34; IGHV3-33;	GO:0006910~phagocytosis, recognition	49	99	49.4949494949495	0	0	0	0	0	0	0
up	IGKV3D-20; IGKV1-12; IGKV2-29; FCN1; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; IGHG3; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; C1S; IGLC2; IGLC3; IGHV1-2; IGLV3-21;	GO:0006956~complement activation	52	92	56.5217391304348	0	0	0	0	0	0	0
up	TNFRSF13B; LILRA1; TRPA1; IFNG; IL2RA; CD3D; CD3G; CXCR1; LAMA1; KLRC1; CXCR3; CCR5; ADGRE1; LILRB2; CLEC1A; ADGRE3; CLEC1B; CLEC4A; TRBV24-1; TRBV6-4; TRBV19; TRBV6-6; TRBV5-1; CD80; TRBV6-1; TRBV27; TRBV5-5; TRBV3-1; TRBV2; TRBV13; TRBV28; TRBV6-2; TRBV11-1; TRBV25-1; TRBV7-2; TRBV4-1; TRBV11-3; TRBV7-6; TRBV29-1; TRBV10-1; TRBV7-7; TRBV14; TRBV15; TRBV30; TRBV10-2; TRBV4-2; TRBV20-1; TRBV7-4; TRBV12-5; TRBV6-5; TRBV12-4; TRBV5-6; TRBV23-1; TRBV5-4; TRBV9; TRBV12-3; TRBV18; TRBV7-9; TRBV11-2; TRBV10-3;	GO:0007166~cell surface receptor signaling pathway	60	268	22.3880597014925	0	0	0	0	0	0	0
up	IGKV3D-20; IGKV1-12; IGKV2-29; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; IGHG3; IGLV7-43; IGKV1-16; IGKV1D-39; IGKV3-11; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; CD3G; IGLC2; IGLC3; FCGR2A; IGHV1-2; FCGR2B; NCKAP1L; IGLV3-21;	GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis	54	135	40	0	0	0	0	0	0	0
up	TRAV19; IGKV3D-20; IGKV1-12; IGKV2-29; CD300LB; NCR3; TYROBP; LILRA1; NCR1; IGKV1-39; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV3-20; IGKV3-15; IGLV1-44; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV2-8; IGLV3-19; IGLV3-1; IGLV3-25; IGLV3-27; IGLV6-57; TRBV12-3; TRAV8-4; IGHV1-69; IGHV1-46; IGHV3-11; IGHV3-48; IGHV3-23; IGHV3-13; IGHV3-53; IGHV3-30; IGHV3-33; IGHV3-7; IGHV2-70; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; TRBC1; IGLV7-43; CD3D; IGKV1-16; IGKV1D-39; IGKV3-11; TRBV7-9; TRAV29DV5; IGKV2-30; IGKV4-1; IGKV5-2; IGHV4-34; CD3G; IGLC2; IGLC3; CD8B; CD19; VCAM1; IGHV1-2; KLRC1; CD1C; CD40LG; FCGR2B; ICAM3; KIR2DL1; KIR2DL3; KIR3DL1; KIR3DL2; IGLV3-21; CD300E; TREML2; LAIR2; CLEC4G; TREML4; CD300LD; LILRB2; LILRB1; CD300LF; KIR2DL4; CD300A; SIGLEC7; BTNL8; BTNL3; BTN1A1;	GO:0050776~regulation of immune response	88	216	40.7407407407407	0	0	0	0	0	0	0
up	MS4A1; CD19; CTLA4; MNDA; NCKAP1L; IGHV4-34; IGHV4-4; IGHV4-61; IGHV3-33; IGHV3-11; IGHV3-72; IGHV3-21; IGHV4-28; IGHV4-39; IGHV1-69-2; IGHV1-2; IGHV2-70; IGHV2-5; IGHV2-26; IGLL5; IGLC3; IGHV3-43; IGHV3-30; IGHV3-13; TRBC2; IGHV5-51; CD79B; IGHG2; IGHV3-23; IGHV1-3; IGHV1-69; IGHV3-73; IGHV1-46; IGHV4-59; IGHV3-64; IGHV6-1; IGHG3; IGHV1-18; IGHV1-24; TRBC1; IGHA2; IGHV3-74; IGHV3-20; TRDC; IGHD; IGHV3-15; IGHV3-66; IGHV3-48; IGLC2; IGHV4-31; IGHV1-58; IGHV3-53; IGHV3-49; IGHV3-7; IGKC;	GO:0050853~B cell receptor signaling pathway	55	125	44	0	0	0	0	0	0	0
up	TLR9; IGHV2-26; IGHV3-53; IGHG3; IGHV3-49; IGHV1-69-2; IGLC3; IGHV3-15; IGHV4-39; IGHV3-64; IGHV4-28; IGHV2-70; IGHV3-21; IGHD; IGHV4-59; IGHV1-69; IGHV4-4; IGHV3-73; IGHV3-23; IGHV3-13; IGHV1-2; TRBC1; IGHV1-18; IGLL5; IGHV1-24; IGHV3-72; IGHV3-74; IGHV3-48; IGHV3-11; TRBC2; IGHG2; IGHV3-33; IGLC2; IGHV3-20; IGHV1-46; IGHV4-31; IGHV5-51; IGHV4-61; IGHV1-3; IGHV6-1; IGHV4-34; IGHV3-66; IGHV1-58; IGHV3-7; IGHA2; TRDC; IGKC; IGHV3-30; IGHV3-43; IGHV2-5;	GO:0050871~positive regulation of B cell activation	50	98	51.0204081632653	0	0	0	0	0	0	0
down	EVPLL; FOXN1; KRT34; GJB5; KRT14; SPRR1B; SPRR2E; SPRR2D; S100A7; CASP14; NTF4; SPRR1A; SPRR2B; SPRR2A; KLK7; BNC1; KRT32; KRT31; CST6; CERS3; ACER1; SPRR2F; SPRR2G; CALML5; SPRR3; KLK5; KRTDAP;	GO:0008544~epidermis development	27	82	32.9268292682927	0	0	0	0	0	0	0
up	HBZ; HBD; HBG1; HBG2; HBA1; HBM;	GO:0015671~oxygen transport	6	14	42.8571428571429	0.00012083582445887	0.0104303286657911	0.226929678333769	0.229467230647405	0.226688006684851	0.226929678333769	0.08476270892269
up	LILRA5; IFNG; ORM1; LPL; ORM2; MMP8; LILRA2;	GO:1904469~positive regulation of tumor necrosis factor secretion	7	22	31.8181818181818	0.00014910334998008	0.0123107505048774	0.279866987912618	0.28314726161218	0.279717884562638	0.279866987912618	0.100044072924296
down	MUC3A; MUC21; B3GNT6; MUC15; MUCL1; MUC13;	GO:0016266~O-glycan processing	6	60	10	0.00015146287197831	0.00796582511885948	0.21113924353777	0.215077278209206	0.199779528139396	0.21113924353777	0.0624200454135085
down	ALOX12B; PSAPL1; ACER1; ALOXE3;	GO:0006665~sphingolipid metabolic process	4	19	21.0526315789474	0.00015722609118429	0.00797360891006056	0.21901594501972	0.223261049481696	0.205556503509672	0.21901594501972	0.0624810390448035
down	CYP1A1; UGT1A7; UGT1A8;	GO:0009804~coumarin metabolic process	3	7	42.8571428571429	0.00019915139053328	0.00975155084680203	0.277218735622327	0.282794974557259	0.24216809088847	0.277218735622327	0.0764129563010882
up	TYROBP; CTLA4; FCGR2B; MNDA; CD300A; TNFRSF13B;	GO:0030889~negative regulation of B cell proliferation	6	16	37.5	0.00021652955550355	0.0171329010792186	0.406209446124665	0.411189625901247	0.405126798347147	0.406209446124665	0.139231576847813
down	CYP1A1; CYP2C9; CYP2C19; CYP2C18;	GO:0019373~epoxygenase P450 pathway	4	21	19.047619047619	0.0002203345241023	0.0104291674741758	0.306485323026307	0.312875024225274	0.2580117277238	0.306485323026307	0.0817227465641809
down	UGT1A9; CYP2C9; UGT1A6; FMO3; CYP2C18; CYP2C19; GSTA1;	GO:0006805~xenobiotic metabolic process	7	94	7.4468085106383	0.00023856662088994	0.010870882477594	0.331607603037025	0.338764601663724	0.271727381193649	0.331607603037025	0.0851840164466839
down	CTSV; MMP7; MMP12; KLK7; TPSAB1; KLK5;	GO:0022617~extracellular matrix disassembly	6	66	9.09090909090909	0.00024497763329789	0.010870882477594	0.340273932650774	0.347868239283009	0.276579747993322	0.340273932650774	0.0851840164466839
down	KRT16; KRT3; KRT6C; EVPLL;	GO:0045104~intermediate filament cytoskeleton organization	4	22	18.1818181818182	0.00025790739759235	0.0110978334721556	0.357975467858181	0.366228504581136	0.286277211327508	0.357975467858181	0.0869623998753682
down	OVOL1; FOXN1; NKX2-8; SPDEF; IL33; CXCL10; FGF1; HOXD8; HOXB1; PAX1; EPCAM; MMP12; ID4; LUM; FOXF1; FOXF2; HNF4G; HES5; MLIP; VGLL2; TFAP2B; OVOL2; SOX17; NKX1-2; DLX5; HOXC9; DLX3; CCDC160; HOXD9;	GO:0045944~positive regulation of transcription by RNA polymerase II	29	1138	2.54833040421793	0.00027000955858358	0.0112768697996673	0.374503257755431	0.383413573188689	0.295374976477655	0.374503257755431	0.0883653249367643
down	UPK1A; GSTA1; KRT3; KRT4; DLX5; DLX3;	GO:0030855~epithelial cell differentiation	6	68	8.82352941176471	0.00028460223507498	0.0115467192516136	0.394458697813925	0.404135173806475	0.306232004940681	0.394458697813925	0.0904798598146912
down	IL20RB; IL36RN; IL36G; IL36B;	GO:0002437~inflammatory response to antigenic stimulus	4	25	16	0.00039811327982142	0.0152789420904437	0.550988779272847	0.565320857346419	0.371790769300633	0.550988779272847	0.119725482912988
down	KRT6A; KRT6B; KRT16; KRT4; CCL11; KRT76; KRT31; PAK5;	GO:0007010~cytoskeleton organization	8	139	5.75539568345324	0.00045401139110423	0.0168193883281553	0.627897753897159	0.644696175368016	0.396805955825103	0.627897753897159	0.131796388648462
down	CYP1A1; CYP2C9; CYP2C19;	GO:0097267~omega-hydroxylase P450 pathway	3	10	30	0.00046194094704088	0.0168193883281553	0.638402388810502	0.655956144798056	0.400040860137406	0.638402388810502	0.131796388648462
up	TRPM2; GATA1; FLT3; LILRB1; BATF3;	GO:0097028~dendritic cell differentiation	5	12	41.6666666666667	0.00050536145525692	0.038387256141316	0.947552728606735	0.959681403532901	0.78886923165606	0.947552728606735	0.311956403571326
down	SCGB1A1; UGT1A1; SERPINB3; UGT1A7; UGT1A8;	GO:0043086~negative regulation of catalytic activity	5	52	9.61538461538462	0.00063944258897874	0.0223182482329682	0.883070215379646	0.908008476349818	0.463691407923577	0.883070215379646	0.174885344263155
up	FFAR3; NCR3; IL18RAP; LY86; ORM1; FOLR2; AZU1; CRHBP; CD40LG; FCGR2B; CNR2; CXCR3; AIF1; NLRP6; FUT7; NAIP; IL27; PLD4; CD180; PROK2; TLR9; STAB1; PF4; PTGDR; CCL23; PF4V1; CCL26; CCR5; XCL1; CCR2; XCL2; IL2RA;	GO:0006954~inflammatory response	32	381	8.3989501312336	0.00064370247102107	0.0470150381718857	1	1	0.9015088887989	0.999999967404819	0.382070606137553
down	IL33; SCGB1A1; IL20RB; PGLYRP3;	GO:0032689~negative regulation of interferon-gamma production	4	29	13.7931034482759	0.0006601172012568	0.0223182482329682	0.91096173773439	0.937366425784663	0.470663564496102	0.910301620533134	0.174885344263155
down	CXCL11; CXCL10; APLNR; BDKRB1;	GO:0051281~positive regulation of release of sequestered calcium ion into cytosol	4	29	13.7931034482759	0.0006601172012568	0.0223182482329682	0.91096173773439	0.937366425784663	0.470663564496102	0.910301620533134	0.174885344263155
down	KRT6A; S100A8; FGF1; EPB41L4B; SPRR3; EVPLL;	GO:0042060~wound healing	6	82	7.31707317073171	0.00072198562743131	0.0238423160686619	0.994896194600345	1	0.490950226653291	0.982887512378637	0.186827909169838
up	LTF; SEMG1; ELANE; RNASE3; DEFA4; BPI; AZU1; DEFA3; RNASE6;	GO:0019730~antimicrobial humoral response	9	52	17.3076923076923	0.00090504612298636	0.0636549106500409	1	1	0.99999996740482	0.999999967404819	0.517295555664065
down	FGF1; ADRA2C; NTF3; DYNAP;	GO:0032148~activation of protein kinase B activity	4	32	12.5	0.00092337167648415	0.027897612353351	1	1	0.549439783004994	0.982887512378637	0.21860512929186
up	APOA2; ELANE; TLR8; TLR7; TLR9;	GO:0045416~positive regulation of interleukin-8 biosynthetic process	5	15	33.3333333333333	0.0011408775024524	0.0747078061088656	1	1	0.99999996740482	0.999999967404819	0.607117592011011
down	DEFB4A; LCE3A; PGLYRP4; PGLYRP3;	GO:0031640~killing of cells of other organism	4	35	11.4285714285714	0.00125291175512809	0.0356847200481983	1	1	0.614284653755027	0.982887512378637	0.27962474856538
down	EDNRB; SERPINB5; HES5;	GO:0050678~regulation of epithelial cell proliferation	3	15	20	0.00125986106858522	0.0356847200481983	1	1	0.615107380699864	0.982887512378637	0.27962474856538
up	LILRA5; LILRB1; TLR8;	GO:2001183~negative regulation of interleukin-12 secretion	3	3	100	0.00130941264900575	0.0828858206820638	1	1	0.99999996740482	0.999999967404819	0.673576731607159
down	HES5; TFAP2B; KLK6; BCL6B;	GO:0045595~regulation of cell differentiation	4	36	11.1111111111111	0.0013789012703902	0.0356847200481983	1	1	0.629603045918422	0.982887512378637	0.27962474856538
down	AKR1B10; LRAT; ADH1B; RBP1; RDH12;	GO:0001523~retinoid metabolic process	5	63	7.93650793650794	0.00142760447925816	0.0356847200481983	1	1	0.635283993269881	0.982887512378637	0.27962474856538
down	MIF; EDN2; PLA2G4F;	GO:0001516~prostaglandin biosynthetic process	3	16	18.75	0.0014826749879181	0.0356847200481983	1	1	0.641998269768536	0.982887512378637	0.27962474856538
down	EDN3; EDN2; ACE2;	GO:0019229~regulation of vasoconstriction	3	16	18.75	0.0014826749879181	0.0356847200481983	1	1	0.641998269768536	0.982887512378637	0.27962474856538
down	ALOX12B; ALOXE3; PLA2G3;	GO:0019372~lipoxygenase pathway	3	16	18.75	0.0014826749879181	0.0356847200481983	1	1	0.641998269768536	0.982887512378637	0.27962474856538
down	EDN3; EDN2; EDNRB;	GO:0042310~vasoconstriction	3	16	18.75	0.0014826749879181	0.0356847200481983	1	1	0.641998269768536	0.982887512378637	0.27962474856538
up	LILRA5; ORM1; LPL; ORM2; LILRA2; TLR8; NLRP7;	GO:0050718~positive regulation of interleukin-1 beta secretion	7	35	20	0.00160735630728548	0.0984635363721008	1	1	0.99999996740482	0.999999967404819	0.800169998514043
down	CLDN17; FXYD3; SLC26A9; CLIC6; GABRQ; GABRA4;	GO:1902476~chloride transmembrane transport	6	97	6.18556701030928	0.00163603776100252	0.0387195603437263	1	1	0.660361493370799	0.982887512378637	0.303405696080925
down	KRT6A; KRT16; SERPINB5;	GO:0002009~morphogenesis of an epithelium	3	17	17.6470588235294	0.00172869811621246	0.0402418250003556	1	1	0.670578946478066	0.982887512378637	0.315334131312727
down	HOXB1; HOXC8; HOXD9; HOXC9; HES2; HES5;	GO:0009952~anterior/posterior pattern specification	6	99	6.06060606060606	0.0018045257393382	0.0413294604816169	1	1	0.678501677991164	0.982887512378637	0.32385682106811
up	TRPM2; CXCR1; CCR2; CCR5; CCR6;	GO:0002407~dendritic cell chemotaxis	5	17	29.4117647058824	0.00180812240158279	0.104049225472901	1	1	0.99999996740482	0.999999967404819	0.845562445344272
down	ALOX12B; GSTA1; ALOXE3;	GO:0043651~linoleic acid metabolic process	3	18	16.6666666666667	0.00199875937005511	0.0423617657534069	1	1	0.69956577951929	0.982887512378637	0.331945944414941
down	KRT20; KRT17; TCHH;	GO:0045109~intermediate filament organization	3	18	16.6666666666667	0.00199875937005511	0.0423617657534069	1	1	0.69956577951929	0.982887512378637	0.331945944414941
down	EDN2; NPNT; NMU;	GO:0045987~positive regulation of smooth muscle contraction	3	18	16.6666666666667	0.00199875937005511	0.0423617657534069	1	1	0.69956577951929	0.982887512378637	0.331945944414941
down	CXCL10; S100A7; CXCL17;	GO:0090026~positive regulation of monocyte chemotaxis	3	18	16.6666666666667	0.00199875937005511	0.0423617657534069	1	1	0.69956577951929	0.982887512378637	0.331945944414941
down	CLDN1; CYP1A1; S100A8; SCGB1A1; UGT1A1; S100A7; BDKRB1;	GO:0032496~response to lipopolysaccharide	7	138	5.07246376811594	0.00203145403394211	0.0424215401205559	1	1	0.703031702605269	0.982887512378637	0.332414335153669
up	TLR9; TLR8; TLR7;	GO:0045356~positive regulation of interferon-alpha biosynthetic process	3	4	75	0.00222049380323208	0.113965344117236	1	1	0.99999996740482	0.999999967404819	0.926146394827027
up	TAL1; SOX8; GCM1;	GO:0060018~astrocyte fate commitment	3	4	75	0.00222049380323208	0.113965344117236	1	1	0.99999996740482	0.999999967404819	0.926146394827027
up	SPTA1; VCAM1; HLA-DMB; CD40LG; AIF1; NCKAP1L; CLECL1; LILRB2; CD80;	GO:0042102~positive regulation of T cell proliferation	9	61	14.7540983606557	0.00243117308536622	0.121494676029223	1	1	0.99999996740482	0.999999967404819	0.987333974786152
down	MMP7; COL15A1; MMP12; KLK6;	GO:0030574~collagen catabolic process	4	43	9.30232558139535	0.00251756540163994	0.0494938213077261	1	1	0.755269620491983	0.982887512378637	0.387832588290448
up	HBA1; HBG2; HBZ; HBD; HBM; HBG1;	GO:0042744~hydrogen peroxide catabolic process	6	28	21.4285714285714	0.00254619716285887	0.123980215699205	1	1	0.99999996740482	0.999999967404819	1
down	CYP1A1; CYP2C9; UGT1A1;	GO:0008210~estrogen metabolic process	3	20	15	0.00261411028033764	0.0494938213077261	1	1	0.763753625514201	0.982887512378637	0.387832588290448
down	EDN3; EDN2; NMU;	GO:0010460~positive regulation of heart rate	3	20	15	0.00261411028033764	0.0494938213077261	1	1	0.763753625514201	0.982887512378637	0.387832588290448
down	EPCAM; DUOXA2; CCL19;	GO:2000147~positive regulation of cell motility	3	20	15	0.00261411028033764	0.0494938213077261	1	1	0.763753625514201	0.982887512378637	0.387832588290448
down	EDN3; EDNRB; NRTN; OVOL2;	GO:0001755~neural crest cell migration	4	44	9.09090909090909	0.00272043856246251	0.0500526214559796	1	1	0.774016526473526	0.982887512378637	0.392211335012929
down	FGF1; S100A7; APLNR; COL15A1; ECSCR; CXCL17; OVOL2; SOX17; TMEM100;	GO:0001525~angiogenesis	9	230	3.91304347826087	0.00274855392280293	0.0500526214559796	1	1	0.776718004371549	0.982887512378637	0.392211335012929
down	CDH16; DSG1; CDH22; PCDHB10;	GO:0016339~calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules	4	45	8.88888888888889	0.00293422833208878	0.0500526214559796	1	1	0.794019528477434	0.982887512378637	0.392211335012929
down	CYP2C19; CYP2C9; CYP2C18;	GO:0006082~organic acid metabolic process	3	21	14.2857142857143	0.00296085929739598	0.0500526214559796	1	1	0.796471150999518	0.982887512378637	0.392211335012929
down	CIDEA; EDN2; NMU;	GO:0001659~temperature homeostasis	3	22	13.6363636363636	0.00333456722104386	0.0557068876927327	1	1	0.82030353637679	0.982887512378637	0.436518051518994
up	CNR2; CD300LF; CD84;	GO:0033004~negative regulation of mast cell activation	3	5	60	0.00344298371187746	0.163455651721382	1	1	0.99999996740482	0.999999967404819	1
up	LTF; GATA1; SOX8; TMEM119;	GO:0033690~positive regulation of osteoblast proliferation	4	12	33.3333333333333	0.00364164213101148	0.168670205043678	1	1	0.99999996740482	0.999999967404819	1
down	LIPK; LIPI; ASPG; PLA2G3; PNLIPRP3;	GO:0016042~lipid catabolic process	5	81	6.17283950617284	0.0039939886066388	0.0590777481398656	1	1	0.850684387884176	0.982887512378637	0.462932046184088
down	ELN; HOXD9; VGLL2; MYOZ1;	GO:0007519~skeletal muscle tissue development	4	50	8	0.0041766543548325	0.0611427750913624	1	1	0.856214142740662	0.982887512378637	0.47911355584181
up	JCHAIN; IGKV3-20; IGHA2; SULF1;	GO:0003094~glomerular filtration	4	13	30.7692307692308	0.00460665156969642	0.203442589089616	1	1	0.99999996740482	0.999999967404819	1
down	CYP2C9; CYP2C19; CYP2C18;	GO:0042738~exogenous drug catabolic process	3	25	12	0.0046236344233912	0.0667442031173968	1	1	0.870979521126599	0.982887512378637	0.523006233191426
down	DEFB4A; S100A8; S100A7; PGLYRP3;	GO:0019730~antimicrobial humoral response	4	52	7.69230769230769	0.00475962116202655	0.0667442031173968	1	1	0.875770293812885	0.982887512378637	0.523006233191426
down	CXCL11; DEFB4A; CXCL14; CXCL10; CCL11; ECSCR;	GO:0006935~chemotaxis	6	122	4.91803278688525	0.00482200022980395	0.0667442031173968	1	1	0.877604041824318	0.982887512378637	0.523006233191426
down	CXCL11; CXCL10; INHA; ACE2; TFAP2B; BCL6B; GKN1;	GO:0042127~regulation of cell population proliferation	7	163	4.29447852760736	0.00489137439533827	0.0667442031173968	1	1	0.880290283743113	0.982887512378637	0.523006233191426
up	CD19; CD180; GAPT;	GO:0002322~B cell proliferation involved in immune response	3	6	50	0.00500520986986985	0.206628120497453	1	1	0.99999996740482	0.999999967404819	1
up	APOA2; ANGPT1; LILRB1;	GO:0002740~negative regulation of cytokine secretion involved in immune response	3	6	50	0.00500520986986985	0.206628120497453	1	1	0.99999996740482	0.999999967404819	1
up	FCGR2B; TMEM176B; LILRB1;	GO:2001199~negative regulation of dendritic cell differentiation	3	6	50	0.00500520986986985	0.206628120497453	1	1	0.99999996740482	0.999999967404819	1
down	EDNRB; BDKRB1; NMU; ALOXE3;	GO:0019233~sensory perception of pain	4	53	7.54716981132075	0.00507057803547672	0.0672027432273241	1	1	0.885972908814224	0.982887512378637	0.526599344270129
down	PLA2G4E; PLA2G4F; PLA2G3;	GO:0036152~phosphatidylethanolamine acyl-chain remodeling	3	26	11.5384615384615	0.00511119455531761	0.0672027432273241	1	1	0.887157796595009	0.982887512378637	0.526599344270129
up	ABRA; GPR55; GPR174; GPR65; F2RL3; P2RY10;	GO:0035025~positive regulation of Rho protein signal transduction	6	33	18.1818181818182	0.00517707690638081	0.20917593713228	1	1	0.99999996740482	0.999999967404819	1
down	EDNRB; NTF3; NTF4;	GO:0007422~peripheral nervous system development	3	27	11.1111111111111	0.00562855175107058	0.0726594862410929	1	1	0.904246100058517	0.982887512378637	0.569358272773704
down	PLA2G4E; PLA2G4F; PLA2G3;	GO:0036151~phosphatidylcholine acyl-chain remodeling	3	27	11.1111111111111	0.00562855175107058	0.0726594862410929	1	1	0.904246100058517	0.982887512378637	0.569358272773704
up	P2RY10; GPR171; P2RY13; P2RY12;	GO:0035589~G protein-coupled purinergic nucleotide receptor signaling pathway	4	14	28.5714285714286	0.00572974740770027	0.222056945453527	1	1	0.99999996740482	0.999999967404819	1
up	IL27; TLR9; TLR8; TLR7;	GO:0045078~positive regulation of interferon-gamma biosynthetic process	4	14	28.5714285714286	0.00572974740770027	0.222056945453527	1	1	0.99999996740482	0.999999967404819	1
down	CYP1A1; CLDN18; FOXF1;	GO:0048565~digestive tract development	3	28	10.7142857142857	0.00617617478267207	0.0756285187019884	1	1	0.921671450927618	0.982887512378637	0.592623551420671
up	FCN1; SIGLEC5; TYROBP; FCGR3B; TRPM2; HP; ORM1; LTF; ELANE; RNASE2; FCGR2A; RNASE3; DEFA4; BPI; CD53; ORM2; AZU1; MMP8; FCAR; CXCR1; CEACAM8; CEACAM3; MNDA; P2RX1; HK3; NCKAP1L; SIGLEC14; CLEC12A; LILRB2; CLEC4C; MS4A3; ADGRE3; RETN; CD300A;	GO:0043312~neutrophil degranulation	34	483	7.03933747412008	0.00639009112590294	0.242695660961794	1	1	0.99999996740482	0.999999967404819	1
down	UGT1A9; CYP1A1; HMGCS2; ACER1; PSAPL1;	GO:0019216~regulation of lipid metabolic process	5	92	5.43478260869565	0.00663477598728002	0.0799282684790406	1	1	0.936442236294877	0.982887512378637	0.626316304192118
down	CXCL11; CXCL14; GNA14; CXCL10; INHA; FGF1; CGB7; SCGB1A1; EDN3; NTF3; COL15A1; CCL11; FAM3B; FGFBP1; FAM3D; SH3GL3; CALML5; PAK5; GABRQ; HTR3B; GABRA4; CBLC;	GO:0007165~signal transduction	22	989	2.22446916076845	0.00673004422886925	0.0799282684790406	1	1	0.939226310821617	0.982887512378637	0.626316304192118
down	ADRA2C; EDNRB; TMEM100;	GO:0051930~regulation of sensory perception of pain	3	29	10.3448275862069	0.00675450156160906	0.0799282684790406	1	1	0.939226310821617	0.982887512378637	0.626316304192118
down	CYP1A1; MT1A; MT1M;	GO:0071280~cellular response to copper ion	3	29	10.3448275862069	0.00675450156160906	0.0799282684790406	1	1	0.939226310821617	0.982887512378637	0.626316304192118
up	FCGR2B; FCRL3; CD300A;	GO:0050859~negative regulation of B cell receptor signaling pathway	3	7	42.8571428571429	0.0069302862387125	0.253088722448366	1	1	0.99999996740482	0.999999967404819	1
up	HP; GZMA; GZMK;	GO:0051354~negative regulation of oxidoreductase activity	3	7	42.8571428571429	0.0069302862387125	0.253088722448366	1	1	0.99999996740482	0.999999967404819	1
down	ADGRL2; CXCL10; INHA; EDN3; MIF; EDN2; EDNRB; ADGRF4; CBLC;	GO:0007166~cell surface receptor signaling pathway	9	268	3.35820895522388	0.00710904914839416	0.0832047932862195	1	1	0.944751171473509	0.982887512378637	0.651991086679922
down	PTPRZ1; GABRA4; KLK6; SH3GL3; ROBO2; SPINK6;	GO:0007417~central nervous system development	6	133	4.51127819548872	0.00714858083163294	0.0832047932862195	1	1	0.944751171473509	0.982887512378637	0.651991086679922
down	CAPN8; GKN1; CYP39A1;	GO:0007586~digestion	3	30	10	0.0073639399976746	0.0840298512985551	1	1	0.947891239149963	0.982887512378637	0.658456224670064
down	DEFB4A; KRT6A; LCE3A; PGLYRP4; PGLYRP3;	GO:0050830~defense response to Gram-positive bacterium	5	95	5.26315789473684	0.00752664283318938	0.0840298512985551	1	1	0.94901211960619	0.982887512378637	0.658456224670064
down	APLNR; FOXF1; SOX17; TMEM100;	GO:0001570~vasculogenesis	4	60	6.66666666666667	0.0076336977588124	0.0840298512985551	1	1	0.950171651112633	0.982887512378637	0.658456224670064
down	FGF1; EDN3; MIF; TPD52L1;	GO:0043406~positive regulation of MAP kinase activity	4	60	6.66666666666667	0.0076336977588124	0.0840298512985551	1	1	0.950171651112633	0.982887512378637	0.658456224670064
down	ALOX12B; CERS3; ALOXE3;	GO:0046513~ceramide biosynthetic process	3	31	9.67741935483871	0.00800486883935703	0.0874377980914383	1	1	0.953253288900025	0.982887512378637	0.685160827194535
up	LILRA5; IFNG; LPL; AIF1; LILRA2; TLR8;	GO:2000778~positive regulation of interleukin-6 secretion	6	37	16.2162162162162	0.00840464130304386	0.286875879868697	1	1	0.99999996740482	0.999999967404819	1
up	PF4; LTF; SEMG1; RNASE3; DEFA4; DEFA3; RNASE6; PF4V1;	GO:0061844~antimicrobial humoral immune response mediated by antimicrobial peptide	8	62	12.9032258064516	0.00849553553051641	0.286875879868697	1	1	0.99999996740482	0.999999967404819	1
up	IFNG; CD40LG; IRF8; SCIMP; TLR9;	GO:0032735~positive regulation of interleukin-12 production	5	26	19.2307692307692	0.00855935472614167	0.286875879868697	1	1	0.99999996740482	0.999999967404819	1
down	SLC6A14; SLC6A1; SLC6A11;	GO:0006810~transport	3	32	9.375	0.00867763849622716	0.0933503535200194	1	1	0.959561582723628	0.982887512378637	0.731491492612754
down	SCNN1G; UGT1A7; ATP6V0A4;	GO:0007588~excretion	3	32	9.375	0.00867763849622716	0.0933503535200194	1	1	0.959561582723628	0.982887512378637	0.731491492612754
up	TLR9; TLR8; TLR7;	GO:0045359~positive regulation of interferon-beta biosynthetic process	3	8	37.5	0.0092365940296848	0.286875879868697	1	1	0.99999996740482	0.999999967404819	1
up	LTF; DEFA4; DEFA3;	GO:0051673~membrane disruption in other organism	3	8	37.5	0.0092365940296848	0.286875879868697	1	1	0.99999996740482	0.999999967404819	1
up	ELANE; CCR2; FUT7;	GO:1903238~positive regulation of leukocyte tethering or rolling	3	8	37.5	0.0092365940296848	0.286875879868697	1	1	0.99999996740482	0.999999967404819	1
down	SAA1; CCL19; CCL11;	GO:0048247~lymphocyte chemotaxis	3	33	9.09090909090909	0.00938257184350233	0.0979650883659802	1	1	0.966183054254786	0.982887512378637	0.767652462048826
up	IFNG; AZU1; AIF1; TLR8; TLR7;	GO:0001774~microglial cell activation	5	27	18.5185185185185	0.00980338218275256	0.286875879868697	1	1	0.99999996740482	0.999999967404819	1
down	EDN2; FOXF1; ABCA12;	GO:0048286~lung alveolus development	3	34	8.82352941176471	0.0101199650091096	0.104132973282142	1	1	0.971939219847213	0.982887512378637	0.815983884196248
down	MAP2; PREX2; DCDC2;	GO:0048813~dendrite morphogenesis	3	34	8.82352941176471	0.0101199650091096	0.104132973282142	1	1	0.971939219847213	0.982887512378637	0.815983884196248
down	KLK8; BRINP1; CIDEA;	GO:0008219~cell death	3	35	8.57142857142857	0.0108900881444285	0.108900881444285	1	1	0.979732546925026	0.982887512378637	0.853345116657121
down	CXCL10; EDN3; ELN;	GO:0008015~blood circulation	3	36	8.33333333333333	0.0116931861768913	0.115307808133234	1	1	0.982887512378637	0.982887512378637	0.903549665328215
up	CSF3; SPI1; CEBPE;	GO:0030851~granulocyte differentiation	3	9	33.3333333333333	0.0119382275375569	0.325620883583961	1	1	0.99999996740482	0.999999967404819	1
up	LY86; SCIMP; CD180;	GO:0031666~positive regulation of lipopolysaccharide-mediated signaling pathway	3	9	33.3333333333333	0.0119382275375569	0.325620883583961	1	1	0.99999996740482	0.999999967404819	1
up	IGHD; ORM1; ORM2;	GO:0050716~positive regulation of interleukin-1 secretion	3	9	33.3333333333333	0.0119382275375569	0.325620883583961	1	1	0.99999996740482	0.999999967404819	1
up	TYROBP; IFNG; AZU1;	GO:0050725~positive regulation of interleukin-1 beta biosynthetic process	3	9	33.3333333333333	0.0119382275375569	0.325620883583961	1	1	0.99999996740482	0.999999967404819	1
up	SPI1; IRF4; BATF; BATF3;	GO:0043011~myeloid dendritic cell differentiation	4	18	22.2222222222222	0.0120028761721312	0.325620883583961	1	1	0.99999996740482	0.999999967404819	1
down	EPCAM; NPNT; ROBO2;	GO:0001657~ureteric bud development	3	37	8.10810810810811	0.0125294795475714	0.117538083514467	1	1	0.982887512378637	0.982887512378637	0.921026058357686
down	SAA1; SAA2; UGT1A1;	GO:0006953~acute-phase response	3	37	8.10810810810811	0.0125294795475714	0.117538083514467	1	1	0.982887512378637	0.982887512378637	0.921026058357686
down	AGR2; FOXF1; NPNT;	GO:0010811~positive regulation of cell-substrate adhesion	3	37	8.10810810810811	0.0125294795475714	0.117538083514467	1	1	0.982887512378637	0.982887512378637	0.921026058357686
down	CXCL11; CXCL10; CCL11; CCL19;	GO:0070098~chemokine-mediated signaling pathway	4	70	5.71428571428571	0.012581541333943	0.117538083514467	1	1	0.982887512378637	0.982887512378637	0.921026058357686
up	ORM1; BPI; NCKAP1L; SLAMF1; TLR9;	GO:0032715~negative regulation of interleukin-6 production	5	29	17.2413793103448	0.0126522277851782	0.338402543155681	1	1	0.99999996740482	0.999999967404819	1
up	LTF; RNASE3; DEFA3; DEFA4;	GO:0002227~innate immune response in mucosa	4	19	21.0526315789474	0.0140599316896387	0.359795333766185	1	1	0.99999996740482	0.999999967404819	1
down	MUC3A; MUC21; MUC15; MUCL1; MUC13;	GO:0002223~stimulatory C-type lectin receptor signaling pathway	5	112	4.46428571428571	0.0141910930818203	0.129175334462723	1	1	0.982887512378637	0.982887512378637	1
down	CXCL14; SAA2; SAA1; DEFB4A;	GO:0060326~cell chemotaxis	4	74	5.40540540540541	0.015022434746589	0.131537745817357	1	1	0.982887512378637	0.982887512378637	1
up	IL18RAP; AVPR2; LILRB1;	GO:0032609~interferon-gamma production	3	10	30	0.0150454072642179	0.359795333766185	1	1	0.99999996740482	0.999999967404819	1
up	CLEC12B; LILRB1; KIR2DL4;	GO:0045953~negative regulation of natural killer cell mediated cytotoxicity	3	10	30	0.0150454072642179	0.359795333766185	1	1	0.99999996740482	0.999999967404819	1
down	SYNPO2L; MYOZ1; TNNT2;	GO:0045214~sarcomere organization	3	40	7.5	0.0152393838334826	0.131537745817357	1	1	0.982887512378637	0.982887512378637	1
up	IL2RA; CTLA4; CLEC4G; LILRB2; LILRB1; CD80;	GO:0042130~negative regulation of T cell proliferation	6	43	13.953488372093	0.0156286021957466	0.359795333766185	1	1	0.99999996740482	0.999999967404819	1
down	MIF; FGFR3; S100A7; SYT14P1; NPNT; CCL19; CCL11;	GO:0070374~positive regulation of ERK1 and ERK2 cascade	7	209	3.34928229665072	0.016815548326599	0.131537745817357	1	1	0.982887512378637	0.982887512378637	1
up	CEACAM4; ICAM3; IRF8; SLAMF1; CEBPE; PLD4; ELANE;	GO:0006909~phagocytosis	7	57	12.280701754386	0.0168281661149277	0.375961028849972	1	1	0.99999996740482	0.999999967404819	1
up	FOLR2; CCR2; CCL23; CCL26; XCL2; XCL1;	GO:0002548~monocyte chemotaxis	6	44	13.6363636363636	0.0171514944451395	0.378728929666511	1	1	0.99999996740482	0.999999967404819	1
down	CXCL10; EDNRB; IL36B; CXCL11; IL36RN; IL36G;	GO:0071222~cellular response to lipopolysaccharide	6	163	3.68098159509202	0.0174533025832107	0.131537745817357	1	1	0.982887512378637	0.982887512378637	1
down	SCGB1A1; DUOXA2; ACE2; BCL6B;	GO:0050727~regulation of inflammatory response	4	78	5.12820512820513	0.0177426616087621	0.131537745817357	1	1	0.982887512378637	0.982887512378637	1
down	CXCL11; DEFB4A; GPR37; ADGRL2; GNA14; CXCL10; SAA1; EDN3; ADRA2C; EDN2; EDNRB; APLNR; BDKRB1; NMU; PREX2; ADGRF4; QRFPR; CCL19; FZD10; CCL11; CGB7; GPR87; MRGPRX3;	GO:0007186~G protein-coupled receptor signaling pathway	23	1152	1.99652777777778	0.0180176274835731	0.131537745817357	1	1	0.982887512378637	0.982887512378637	1
up	LTF; MS4A1; CCR2; CCR6; JCHAIN; IFNG; AIRE;	GO:0006959~humoral immune response	7	58	12.0689655172414	0.0182018145996793	0.397301677296448	1	1	0.99999996740482	0.999999967404819	1
down	DLX3; FOXF1; APLNR;	GO:0001568~blood vessel development	3	43	6.97674418604651	0.01825377967506	0.131537745817357	1	1	0.982887512378637	0.982887512378637	1
down	SCGB1A1; IL20RB; VTCN1;	GO:0042130~negative regulation of T cell proliferation	3	43	6.97674418604651	0.01825377967506	0.131537745817357	1	1	0.982887512378637	0.982887512378637	1
down	CDH16; CEACAM5; DSG1; ROBO2; CDH22; PCDHB10;	GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules	6	165	3.63636363636364	0.0183806916480853	0.131537745817357	1	1	0.982887512378637	0.982887512378637	1
up	ELANE; CCR6; FUT7;	GO:0002523~leukocyte migration involved in inflammatory response	3	11	27.2727272727273	0.0185648624393631	0.400621292867619	1	1	0.99999996740482	0.999999967404819	1
up	TYROBP; IFNG; AZU1; CCR2;	GO:0042535~positive regulation of tumor necrosis factor biosynthetic process	4	21	19.047619047619	0.0188106983898743	0.401365351037879	1	1	0.99999996740482	0.999999967404819	1
down	CLDN1; KRT14; CYP1A1; KRT16; MMP7; EDNRB;	GO:0007568~aging	6	166	3.6144578313253	0.0188567842476796	0.131537745817357	1	1	0.982887512378637	0.982887512378637	1
down	DEFB4A; S100A7; LCE3A; NLRP10;	GO:0050829~defense response to Gram-negative bacterium	4	80	5	0.0192102093227318	0.131537745817357	1	1	0.982887512378637	0.982887512378637	1
down	CLEC3B; FGFR3; TUFT1;	GO:0030282~bone mineralization	3	44	6.81818181818182	0.0193267033755053	0.131537745817357	1	1	0.982887512378637	0.982887512378637	1
down	HOXB1; HOXD9; HOXC9;	GO:0048704~embryonic skeletal system morphogenesis	3	44	6.81818181818182	0.0193267033755053	0.131537745817357	1	1	0.982887512378637	0.982887512378637	1
down	CYP1A1; FOXF1; PLA2G4F;	GO:0071407~cellular response to organic cyclic compound	3	45	6.66666666666667	0.0204337876965264	0.131537745817357	1	1	0.982887512378637	0.982887512378637	1
up	AZU1; CCR6; CCR5; CXCR5; CXCR3; CXCR1; CCR2; CCR8;	GO:0060326~cell chemotaxis	8	74	10.8108108108108	0.0208015006645889	0.438911664022825	1	1	0.99999996740482	0.999999967404819	1
down	KLK8; PAK5; NTF3; NTF4;	GO:0007613~memory	4	83	4.81927710843374	0.0215484483920078	0.131537745817357	1	1	0.982887512378637	0.982887512378637	1
up	IL2RA; CTLA4; FCGR2B;	GO:0050777~negative regulation of immune response	3	12	25	0.0225001849200586	0.459280466086636	1	1	0.99999996740482	0.999999967404819	1
down	EDN2; EDNRB; CALML5; CALML3;	GO:0019722~calcium-mediated signaling	4	85	4.70588235294118	0.0231997414351957	0.131537745817357	1	1	0.982887512378637	0.982887512378637	1
up	XCL1; NCKAP1L; XCL2; CXCR1; PF4; CCL26; CCL23; PF4V1;	GO:0030593~neutrophil chemotaxis	8	76	10.5263157894737	0.0236810511632631	0.463611506794193	1	1	0.99999996740482	0.999999967404819	1
down	HOXD9; NTF4; PREX2;	GO:0008344~adult locomotory behavior	3	48	6.25	0.0239602218838154	0.131537745817357	1	1	0.982887512378637	0.982887512378637	1
down	RHOD; SAA1; EPB41L4B;	GO:0045785~positive regulation of cell adhesion	3	48	6.25	0.0239602218838154	0.131537745817357	1	1	0.982887512378637	0.982887512378637	1
down	RHOD; CLDN1; FGF1; NTF3; SERPINB3; CCL11; FOXF1;	GO:0030335~positive regulation of cell migration	7	226	3.09734513274336	0.024240920048462	0.131885465397763	1	1	0.982887512378637	0.982887512378637	1
up	CD300LD; CD300LF; CTLA4; IRF8; IRF4;	GO:0002376~immune system process	5	35	14.2857142857143	0.0244050986811222	0.472911044851541	1	1	0.99999996740482	0.999999967404819	1
up	HP; HBZ; HBD; HBG1; HBG2; HBA1; HBM; LOXHD1;	GO:0098869~cellular oxidant detoxification	8	77	10.3896103896104	0.025220843086974	0.483781626486502	1	1	0.99999996740482	0.999999967404819	1
up	POMC; ORM1; BPI; LILRA4; SLAMF1; CLEC4A;	GO:0032720~negative regulation of tumor necrosis factor production	6	49	12.2448979591837	0.0263008676020591	0.499453475763102	1	1	0.99999996740482	0.999999967404819	1
up	CD19; FCGR2B; TLR8;	GO:0016064~immunoglobulin mediated immune response	3	13	23.0769230769231	0.0268521563329087	0.504873711645482	1	1	0.99999996740482	0.999999967404819	1
up	PF4; CXCR5; CNR2; PF4V1;	GO:0030595~leukocyte chemotaxis	4	24	16.6666666666667	0.0276058762857481	0.508966592879957	1	1	0.99999996740482	0.999999967404819	1
up	PF4; IRF8; IRF4; BATF;	GO:0042832~defense response to protozoan	4	24	16.6666666666667	0.0276058762857481	0.508966592879957	1	1	0.99999996740482	0.999999967404819	1
down	ALDH3B2; CERS3; ACER1;	GO:0030148~sphingolipid biosynthetic process	3	52	5.76923076923077	0.0291402608571596	0.153825912331474	1	1	0.982887512378637	0.982887512378637	1
down	GABRQ; HTR3B; GABRA4;	GO:0050877~nervous system process	3	52	5.76923076923077	0.0291402608571596	0.153825912331474	1	1	0.982887512378637	0.982887512378637	1
down	KLK6; MAL2; MALL;	GO:0042552~myelination	3	53	5.66037735849057	0.0305202970664471	0.155373440911537	1	1	0.982887512378637	0.982887512378637	1
down	ARHGEF15; CALML3; CALML5;	GO:0050790~regulation of catalytic activity	3	53	5.66037735849057	0.0305202970664471	0.155373440911537	1	1	0.982887512378637	0.982887512378637	1
up	CD40LG; XCL1; TIGIT; TLR9;	GO:0032733~positive regulation of interleukin-10 production	4	25	16	0.0309977542566191	0.523202407949581	1	1	0.99999996740482	0.999999967404819	1
up	HBZ; EPB42; TAL1;	GO:0043249~erythrocyte maturation	3	14	21.4285714285714	0.0316190502107319	0.523202407949581	1	1	0.99999996740482	0.999999967404819	1
up	UPK3A; SLC12A3; SLC12A1;	GO:0055078~sodium ion homeostasis	3	14	21.4285714285714	0.0316190502107319	0.523202407949581	1	1	0.99999996740482	0.999999967404819	1
down	CYP1A1; PAX1; DLX5; SDCBP2; PAK5;	GO:0008283~cell population proliferation	5	142	3.52112676056338	0.0338413963706015	0.155373440911537	1	1	0.982887512378637	0.982887512378637	1
up	CD3G; CD80; SLA; GRAP; SKAP1; FCRL2; ROPN1B;	GO:0009967~positive regulation of signal transduction	7	67	10.4477611940298	0.0342393796585724	0.523202407949581	1	1	0.99999996740482	0.999999967404819	1
down	CLDN1; CLEC3B; OVOL2;	GO:0071560~cellular response to transforming growth factor beta stimulus	3	56	5.35714285714286	0.0348629699007725	0.155373440911537	1	1	0.982887512378637	0.982887512378637	1
up	GPR65; P2RY10; F2RL3; GPR174; GPR55;	GO:0051482~positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway	5	39	12.8205128205128	0.0351963618608975	0.523202407949581	1	1	0.99999996740482	0.999999967404819	1
up	MMP8; SCIMP; LILRB2; TLR9; TLR8; TLR7;	GO:0032755~positive regulation of interleukin-6 production	6	53	11.3207547169811	0.0355998877236116	0.523202407949581	1	1	0.99999996740482	0.999999967404819	1
down	PLA2G4E; PLA2G4F; PLA2G3;	GO:0006644~phospholipid metabolic process	3	57	5.26315789473684	0.0363776344852182	0.156808198552646	1	1	0.982887512378637	0.982887512378637	1
up	NLRP6; IRF4; TLR9;	GO:0034122~negative regulation of toll-like receptor signaling pathway	3	15	20	0.0367969107713637	0.523202407949581	1	1	0.99999996740482	0.999999967404819	1
up	IFNG; IL2RA; CTLA4;	GO:0045589~regulation of regulatory T cell differentiation	3	15	20	0.0367969107713637	0.523202407949581	1	1	0.99999996740482	0.999999967404819	1
up	IFNG; FCER2; TLR9;	GO:0051770~positive regulation of nitric-oxide synthase biosynthetic process	3	15	20	0.0367969107713637	0.523202407949581	1	1	0.99999996740482	0.999999967404819	1
up	JCHAIN; IGKC; IGHG3; IGHA2; LTF;	GO:0001895~retina homeostasis	5	40	12.5	0.0382873258375178	0.523202407949581	1	1	0.99999996740482	0.999999967404819	1
up	RCVRN; CABP4; TRPC3; GPR88;	GO:0007602~phototransduction	4	27	14.8148148148148	0.0384851263205742	0.523202407949581	1	1	0.99999996740482	0.999999967404819	1
down	SAA1; EDN2; EDNRB; BDKRB1; NMU;	GO:0007204~positive regulation of cytosolic calcium ion concentration	5	150	3.33333333333333	0.0409944819206824	0.163220839236939	1	1	0.982887512378637	0.982887512378637	1
down	CXCL10; NTF3; CARD18; DYNAP; CIDEA; CIDEC;	GO:0042981~regulation of apoptotic process	6	202	2.97029702970297	0.0419678089828832	0.163220839236939	1	1	0.982887512378637	0.982887512378637	1
up	CCR2; XCL1; XCL2;	GO:0010820~positive regulation of T cell chemotaxis	3	16	18.75	0.0423798098857829	0.523202407949581	1	1	0.99999996740482	0.999999967404819	1
up	TLR9; TLR8; TLR7;	GO:0034162~toll-like receptor 9 signaling pathway	3	16	18.75	0.0423798098857829	0.523202407949581	1	1	0.99999996740482	0.999999967404819	1
up	UPK3A; SLC12A3; SLC12A1;	GO:0055075~potassium ion homeostasis	3	16	18.75	0.0423798098857829	0.523202407949581	1	1	0.99999996740482	0.999999967404819	1
down	KLK8; CYP1A1; KLK6;	GO:0009611~response to wounding	3	62	4.83870967741935	0.0444472804736067	0.163220839236939	1	1	0.982887512378637	0.982887512378637	1
down	KLK8; NTF3; NTF4;	GO:0048812~neuron projection morphogenesis	3	62	4.83870967741935	0.0444472804736067	0.163220839236939	1	1	0.982887512378637	0.982887512378637	1
down	SCNN1G; FXYD3; ATP6V0A4; GABRQ; GABRA4; HTR3B;	GO:0034220~ion transmembrane transport	6	208	2.88461538461538	0.047026479576888	0.163220839236939	1	1	0.982887512378637	0.982887512378637	1
up	GATA1; NCKAP1L; RHAG;	GO:0048821~erythrocyte development	3	17	17.6470588235294	0.0483600836905265	0.523202407949581	1	1	0.99999996740482	0.999999967404819	1
up	AIF1; P2RY12; CCL26;	GO:0050921~positive regulation of chemotaxis	3	17	17.6470588235294	0.0483600836905265	0.523202407949581	1	1	0.99999996740482	0.999999967404819	1
down	GPR37; ALOX12B; ADRA2C; FGFR3;	GO:0043410~positive regulation of MAPK cascade	4	109	3.6697247706422	0.048971500883088	0.166362514961686	1	1	0.982887512378637	0.982887512378637	1
